Autonomous car developer Waymo has snatched up its first external funding, with parent company Alphabet, Magna International and AutoNation all investing.
Month: March 2020
Rigetti rigs up $71m round
Bloomberg-backed quantum computing technology developer Rigetti Computing has raised an initial $71m for a funding round with an $83.9m targeted close.
Immunocore imports $130m in series B round
Eli Lilly and WuXi AppTec contributed to what was reportedly a down round for T-cell oncology treatment developer Immunocore following a $320m raise in 2015.
Ladder adds series C financing
The Allianz and Northwestern Mutual-backed life insurance portal received $37.5m in a round led by Brewer Lane Ventures that took its overall funding past $90m.
Snapask gets a $35m answer
The mobile tutoring platform developer, a graduate of Singapore Press Holdings’ SPH Plug & Play Accelerator, plans to now expand geographically.
MParticle carts in $45m
Arrowroot Capital has led a series D round for customer relationship management platform mParticle, whose existing backers include Alphabet subsidiary GV.
Evonetix engineers $30m in funding
Cambridge Consultants has reinvested in gene synthesis platform developer Evonetix, helping it increase its lifetime funding to $46m.
Elan chips in for Metanoia round
Elan Microelectronics invested in a $19.5m round for spinoff Metanoia Communications, which is preparing to launch its latest broadband chipsets.
Kimbel hits Silicon Road after WeWork
Silicon Road Ventures has hired Ross Kimbel, who had previously ran WeWork Labs for five months, as managing director.
Revo Capital revs up second fund
Corporates Enerjisa and Yildiz Holding have contributed to venture firm Revo Capital’s second fund, which has notched up $45.5m for its first close.
Mail.ru amasses majority share of Skillbox
The corporate has expanded its share in online IT and design university operator Skillbox after two investments in the company in 2019.
Drawing the right lessons from peak activity
Daren Fonda’s excellent article in Barron’s, Venture Capital Attracts the Corporate Crowd, rightly asks why corporate capital is flooding in as deal activity and valuations may be peaking.
Xilio slides to nine-figure series B round
The immuno-oncology therapy developer has raised a sliver over $100m, Takeda Ventures leading a round that included M Ventures, Ipsen Ventures and MRL Ventures Fund.
Accolade accelerates toward public markets
The Comcast, McKesson, Humana and Independence Health-backed digital health concierge developer has set an initial target of $100m for its proposed flotation.